GlassScriptPhysician profile
Julie Paul
NPI 1740741669
$2,420.55
in general payments reported to CMS, 2019-2025
17 companies · $1,796 in 2025
The $1,796 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $625 · 2025: $1,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,144 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,143.58 |
| Education | $276.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $413.70 | 2024-2025 | Tremfya |
| Abbvie INC. | $398.93 | 2024-2025 | |
| Ucb, INC. | $389.25 | 2024-2025 | Bimzelx, Cimzia |
| Amgen INC. | $376.00 | 2024-2025 | Tavneos, Krystexxa, Uplizna |
| Novartis Pharmaceuticals Corporation | $180.41 | 2024-2025 | |
| Lilly USA, LLC | $174.38 | 2024-2025 | Zepbound, Taltz |
| Pfizer INC. | $116.98 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $113.25 | 2024-2025 | Strensiq |
| Invivyd INC | $57.00 | 2025 | Pemgarda |
| Aurinia Pharma U.S., INC. | $48.58 | 2024-2025 | Lupkynis |
| Radius Health, INC. | $32.46 | 2025 | Tymlos |
| Genentech USA, INC. | $29.29 | 2024-2025 | Actemra |
| Glaxosmithkline, LLC. | $25.35 | 2025 | Benlysta |
| Mallinckrodt Hospital Products INC. | $19.27 | 2025 | Acthar |
| Sandoz INC. | $16.17 | 2025 | Jubbonti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14.82 | 2024 | |
| Ani Pharmaceuticals, INC. | $14.71 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.